A recent report released by Information Services Group (ISG) on October 28, 2025, highlights a significant trend among European medical device manufacturers toward digital transformation. The report, titled the 2025 ISG Provider Lens® Medical Device Digital Services for Europe, underscores how these companies are leveraging advanced technologies to modernize their regulatory operations, enhance post-market surveillance, and improve patient safety.

2. Measurable Outcomes from Digital Innovations

According to ISG, European medical device makers are already witnessing quantifiable benefits from their digital transformation efforts. Companies are not only reducing operational costs but also enhancing device performance and maximizing the return on their technology investments. Sven Geissler, a director at ISG, stated, “European medical device makers are realizing measurable results from digital transformation.”

Addressing Evolving Challenges

The report reveals that enterprises are utilizing digital platforms and solutions to optimize their operations in response to an aging population, shifting regulations, and rapid technological advancements. Key initiatives include:

Upgrading Quality and Vigilance Systems: Companies are aligning their practices with the European Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Device Regulation (IVDR) to enhance compliance.

Automation in Regulatory Processes: Regulatory documentation, compliance reporting, and post-market monitoring are being automated to boost efficiency and accuracy.

3. The Shift to Patient-Centered Models

A notable trend in the industry is the expansion of remote care capabilities, facilitating a transition toward more patient-centered models. Through telemedicine and connected monitoring tools, manufacturers can better serve aging populations and manage chronic diseases while adhering to regulatory timelines. Integrated patient engagement platforms are being employed to collect feedback and track adherence, which in turn improves oversight and responsiveness.

Regional Disparities in Adoption Rates

While Western Europe is leading the charge in adopting these technologies, the medical device industry in Eastern Europe is also beginning to invest in compliance operations, regional regulatory intelligence, and multilingual hubs to streamline post-market reporting.

4. The Role of Generative AI and Digital Twins

The report highlights the increasing adoption of Generative AI (GenAI) among enterprises to enhance regulatory submissions, vigilance reporting, and quality documentation. This shift is aimed at reducing manual workloads while improving accuracy. Additionally, the implementation of digital twins and advanced analytics is enabling companies to validate device performance and anticipate potential component failures, thereby bolstering device reliability and safety.

Enhanced Quality Management Systems

Upgraded digital quality management systems are tracking corrective actions and audit findings in real-time, allowing for quicker regulatory responses and improved compliance outcomes.

5. Collaboration and Co-Innovation in the Industry

Many device makers are engaging with service providers to enhance their operations and prepare for future technologies. Co-innovation labs are being established to expedite usability testing and device validation, resulting in improved safety and audit outcomes. Outcome-based pricing models, which link fees to successful outcomes like regulatory approvals and complaint resolutions, are also gaining traction.

Strategic Insights from ISG Analysts

Sneha Jayanth, lead analyst for ISG Provider Lens Research, emphasized the importance of aligning compliance with innovation. She noted that “enterprises that align compliance with innovation are achieving greater operational stability and market access.” Furthermore, she highlighted the burgeoning need for validated AI tools, compliance-ready cloud platforms, and secure data pipelines as essential capabilities for medical device manufacturers.

6. Trends and Future Directions

The report also addresses additional trends within Europe’s medical device sector, including the growing adoption of digital-first quality management systems and the integration of sustainability objectives into regulatory strategies.

7. Evaluation of Service Providers

The 2025 ISG Provider Lens® report evaluates the capabilities of 21 providers across three primary quadrants: Digital Engineering and Product Development, Regulatory Compliance, Strategy and Quality Assurance, and Post-Market Digital Enablement. Among the key findings:

Leaders: Accenture, Cognizant, HCLTech, Infosys, TCS, and Wipro were identified as Leaders in three quadrants each.

Other Notable Providers: Capgemini was recognized as a Leader in two quadrants, while Deloitte and LTTS were acknowledged as Leaders in one quadrant each.

Rising Stars: LTTS was identified as a Rising Star in two quadrants, and HARMAN in one.

8. Conclusion

The 2025 ISG Provider Lens® Medical Device Digital Services report reveals a dynamic landscape for European medical device manufacturers as they navigate the complexities of digital transformation. By embracing AI and modern technologies, these companies are not only enhancing operational efficiencies but are also paving the way for improved patient outcomes and compliance in an increasingly regulated environment. For further insights into the challenges faced by medical device digital services in Europe, the full report is available for subscribers or for one-time purchase.

Original press release